National Center for Advancing Translational Sciences

Connects National Center for Advancing Translational Sciences to support practical collaboration across research and industry.

The National Center for Advancing Translational Sciences, or NCATS, is an NIH center built to improve how discoveries move into patient care. It funds translational science methods, tools, and workforce rather than disease-specific research, and it sits inside the National Institutes of Health under the Department of Health and Human Services. Its role is to strengthen the machinery of translation, not to sponsor a single disease silo.

NCATS funds the Clinical and Translational Science Awards, the Rare Diseases Clinical Research Network, the Therapeutics for Rare and Neglected Diseases program, the ASPIRE platform, tissue-chip work, drug-screening platforms, SBIR and STTR support, conference grants, and challenge and prize competitions. The record points to clinical technology, instruments, and devices with broad applications as especially relevant areas, and its small-business work is built around those enabling technologies. Its mix includes grants and cooperative agreements, with major collaborative platforms sitting beside smaller innovation awards.

The center is best suited to applicants with methods, infrastructure, or enabling technologies that can help many projects at once. Strong proposals usually show cross-disease utility, a clear adoption path, or a way to remove friction from the translational process. NCATS is therefore a good fit for teams that think less about one endpoint and more about the systems that let many studies advance faster.